MX394585B - Beta-caseina a2 y reducción y prevención de síntomas de intolerancia a la lactosa. - Google Patents
Beta-caseina a2 y reducción y prevención de síntomas de intolerancia a la lactosa.Info
- Publication number
- MX394585B MX394585B MX2019012446A MX2019012446A MX394585B MX 394585 B MX394585 B MX 394585B MX 2019012446 A MX2019012446 A MX 2019012446A MX 2019012446 A MX2019012446 A MX 2019012446A MX 394585 B MX394585 B MX 394585B
- Authority
- MX
- Mexico
- Prior art keywords
- casein
- beta
- prevention
- reduction
- lactose intolerance
- Prior art date
Links
- 102000011632 Caseins Human genes 0.000 title abstract 4
- 108010076119 Caseins Proteins 0.000 title abstract 4
- 235000021247 β-casein Nutrition 0.000 title abstract 4
- 201000010538 Lactose Intolerance Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Marine Sciences & Fisheries (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Confectionery (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361845480P | 2013-07-12 | 2013-07-12 | |
| PCT/NZ2014/000141 WO2015005804A1 (en) | 2013-07-12 | 2014-07-10 | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019012446A MX2019012446A (es) | 2020-02-03 |
| MX394585B true MX394585B (es) | 2025-03-04 |
Family
ID=52280344
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019012446A MX394585B (es) | 2013-07-12 | 2014-07-10 | Beta-caseina a2 y reducción y prevención de síntomas de intolerancia a la lactosa. |
| MX2016000308A MX368912B (es) | 2013-07-12 | 2014-07-10 | Beta-caseína a2 y reducción y prevención de síntomas de intolerancia a la lactosa. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016000308A MX368912B (es) | 2013-07-12 | 2014-07-10 | Beta-caseína a2 y reducción y prevención de síntomas de intolerancia a la lactosa. |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US20160136238A1 (https=) |
| EP (2) | EP3542805A1 (https=) |
| JP (2) | JP6436592B2 (https=) |
| KR (2) | KR102367941B1 (https=) |
| CN (3) | CN114832092A (https=) |
| AU (2) | AU2014287862B2 (https=) |
| BR (1) | BR112016000612B8 (https=) |
| CA (2) | CA2917492C (https=) |
| CL (1) | CL2016000064A1 (https=) |
| DK (1) | DK3019180T3 (https=) |
| ES (1) | ES2743194T3 (https=) |
| IL (2) | IL243366B (https=) |
| MX (2) | MX394585B (https=) |
| MY (2) | MY190309A (https=) |
| NZ (2) | NZ715985A (https=) |
| PH (2) | PH12016500032B1 (https=) |
| RU (1) | RU2671562C2 (https=) |
| SG (2) | SG11201510707YA (https=) |
| WO (1) | WO2015005804A1 (https=) |
| ZA (1) | ZA201600007B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2742306T3 (es) * | 2013-05-31 | 2020-02-13 | A2 Milk Co Ltd | Composición que comprende beta-caseína A2 para su uso en la prevención de la inflamación del intestino |
| EP3297643A4 (en) * | 2015-05-22 | 2019-02-06 | The A2 Milk Company Limited | BETA-CASEIN-A2 AND ANTIOXIDATIVE CAPACITY |
| WO2017003300A1 (en) * | 2015-06-29 | 2017-01-05 | The A2 Milk Company Limited | A2 beta-casein and viscosity of milk products |
| JP7394527B2 (ja) * | 2016-03-30 | 2023-12-08 | ズィ・エイツー・ミルク・カンパニー・リミテッド | ベータカゼイン類および認知機能 |
| WO2018063008A1 (en) | 2016-09-30 | 2018-04-05 | The A2 Milk Company Limited | Beta-caseins and gut microbiota |
| NL2019906B1 (en) * | 2017-11-14 | 2019-05-20 | Ausnutria Hyproca B V | Composition comprising a2 b-casein and a vegetable fat mixture |
| CN112205476A (zh) * | 2019-07-11 | 2021-01-12 | 北京三元食品股份有限公司 | β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用 |
| WO2021003741A1 (zh) * | 2019-07-11 | 2021-01-14 | 北京三元食品股份有限公司 | β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用 |
| WO2023010129A2 (en) * | 2021-07-30 | 2023-02-02 | Active Genomes Expressed Diagnostics, Corp. | Methods and compositions for treating liver cancer and liver disease |
| CN121604896A (zh) * | 2023-04-25 | 2026-03-03 | 艾尔牛奶有限公司 | 婴儿乳配方中的β-酪蛋白和在减少婴儿反流发作中的用途 |
| WO2024225918A1 (en) * | 2023-04-25 | 2024-10-31 | The A2 Milk Company Limited | Beta-caseins in infant milk formula and use for reducing crying episodes in infants |
| CN117322467A (zh) * | 2023-10-11 | 2024-01-02 | 东北农业大学 | A2β-酪蛋白在制备功能性食品中的应用 |
| CN117322466A (zh) * | 2023-11-02 | 2024-01-02 | 光明乳业股份有限公司 | 一种新型婴幼儿食用的发酵乳及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2204245C (en) | 1994-11-04 | 2008-07-22 | Robert Bartlett Elliott | Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected |
| CA2217820C (en) | 1995-05-16 | 2011-03-01 | Corran Norman Stuart Mclachlan | Milk and milk products for preventing or treating heart disease |
| US7094949B2 (en) * | 1995-05-16 | 2006-08-22 | A2 Corporation Limited | Breeding and milking cows for milk free of β-casein A1 |
| US7029702B2 (en) * | 1998-07-07 | 2006-04-18 | Ritter Natural Sciences Llc | Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| AU771754B2 (en) | 1999-06-29 | 2004-04-01 | New Zealand Milk Institute Limited, The | Prophylactic dietary supplement based on milk |
| AU9037401A (en) | 2000-09-08 | 2002-03-22 | New Zealand Dairy Board | Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders |
| US20060280802A1 (en) * | 2002-10-04 | 2006-12-14 | Campbell Julie H | Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2 |
| HUE044812T2 (hu) * | 2003-09-23 | 2019-11-28 | Dsm Ip Assets Bv | Prolinspecifikus endoproteázok alkalmazása peptidek és fehérjék hidrolízisére |
| US7618669B2 (en) * | 2005-06-01 | 2009-11-17 | Mead Johnson Nutrition Company | Low-lactose partially hydrolyzed infant formula |
| CN1899054A (zh) * | 2006-07-17 | 2007-01-24 | 颜贻谦 | 去糖牛奶的制作方法 |
| US20120093973A1 (en) * | 2009-04-03 | 2012-04-19 | Mukund Parthasarathy | Milk-like beverages |
| AU2010238184B2 (en) * | 2009-04-15 | 2014-09-04 | Glanbia Nutritionals (Ireland) Limited | A reduced lactose milk product and a process for the preparation thereof |
| DE102010009582A1 (de) * | 2010-02-05 | 2011-08-11 | Vitacare GmbH & Co. KG, 60318 | Mittel zur Anwendung bei Lactasemangel und Lactoseintoleranz |
| MX389785B (es) * | 2011-07-26 | 2025-03-18 | Nucitec Sa De Cv | Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento. |
| CN103315063A (zh) * | 2012-03-19 | 2013-09-25 | 基斯有限公司 | 可预防疾病的婴儿配方奶粉 |
| ES2742306T3 (es) * | 2013-05-31 | 2020-02-13 | A2 Milk Co Ltd | Composición que comprende beta-caseína A2 para su uso en la prevención de la inflamación del intestino |
| US20170086481A1 (en) * | 2014-06-03 | 2017-03-30 | Abbott Laboratories | Nutritional compositions comprising a lipophilic active ingredient |
-
2014
- 2014-07-10 SG SG11201510707YA patent/SG11201510707YA/en unknown
- 2014-07-10 DK DK14823628.4T patent/DK3019180T3/da active
- 2014-07-10 NZ NZ715985A patent/NZ715985A/en unknown
- 2014-07-10 CA CA2917492A patent/CA2917492C/en active Active
- 2014-07-10 CN CN202210552915.8A patent/CN114832092A/zh active Pending
- 2014-07-10 EP EP19169651.7A patent/EP3542805A1/en active Pending
- 2014-07-10 EP EP14823628.4A patent/EP3019180B1/en not_active Revoked
- 2014-07-10 JP JP2016525322A patent/JP6436592B2/ja active Active
- 2014-07-10 AU AU2014287862A patent/AU2014287862B2/en active Active
- 2014-07-10 ES ES14823628T patent/ES2743194T3/es active Active
- 2014-07-10 NZ NZ754642A patent/NZ754642A/en unknown
- 2014-07-10 MX MX2019012446A patent/MX394585B/es unknown
- 2014-07-10 MY MYPI2019006591A patent/MY190309A/en unknown
- 2014-07-10 CN CN201911100359.5A patent/CN110800803A/zh active Pending
- 2014-07-10 CA CA3214545A patent/CA3214545A1/en active Pending
- 2014-07-10 RU RU2015156804A patent/RU2671562C2/ru active
- 2014-07-10 SG SG10201710237PA patent/SG10201710237PA/en unknown
- 2014-07-10 MY MYPI2016700051A patent/MY172939A/en unknown
- 2014-07-10 CN CN201480039570.XA patent/CN105431156A/zh active Pending
- 2014-07-10 MX MX2016000308A patent/MX368912B/es active IP Right Grant
- 2014-07-10 KR KR1020167003267A patent/KR102367941B1/ko active Active
- 2014-07-10 KR KR1020207019514A patent/KR102291660B1/ko active Active
- 2014-07-10 BR BR112016000612A patent/BR112016000612B8/pt active IP Right Grant
- 2014-07-10 US US14/904,178 patent/US20160136238A1/en not_active Abandoned
- 2014-07-10 WO PCT/NZ2014/000141 patent/WO2015005804A1/en not_active Ceased
-
2015
- 2015-12-27 IL IL243366A patent/IL243366B/en active IP Right Grant
-
2016
- 2016-01-04 ZA ZA2016/00007A patent/ZA201600007B/en unknown
- 2016-01-05 PH PH12016500032A patent/PH12016500032B1/en unknown
- 2016-01-12 CL CL2016000064A patent/CL2016000064A1/es unknown
-
2018
- 2018-08-13 IL IL261143A patent/IL261143B/en active IP Right Grant
- 2018-08-17 JP JP2018153472A patent/JP6990154B2/ja active Active
-
2019
- 2019-05-27 AU AU2019203684A patent/AU2019203684B2/en active Active
- 2019-07-03 PH PH12019550112A patent/PH12019550112A1/en unknown
-
2020
- 2020-01-09 US US16/738,792 patent/US20200147173A1/en not_active Abandoned
-
2021
- 2021-12-21 US US17/557,343 patent/US20220175882A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX394585B (es) | Beta-caseina a2 y reducción y prevención de síntomas de intolerancia a la lactosa. | |
| PH12019550096A1 (en) | Beta-casein a2 and prevention of inflammation of the bowel | |
| EA201690582A1 (ru) | Модуляторы фактора в комплемента | |
| JP2013546230A5 (https=) | ||
| UY34763A (es) | Inhibidores de la agregación plaquetaria | |
| UY34200A (es) | 3-(fluorovinil)pirazoles y su uso | |
| TWD161785S (zh) | 皮帶調節具 | |
| MY192873A (en) | Beta-casein a2 and blood glucose levels | |
| MX2015011837A (es) | Co-cristale de pirimetanil y tetracarboximida de ditiina seleccionada. | |
| IN2015DN01524A (https=) | ||
| ES2508165T3 (es) | Lactoferrina y sustancia blanca | |
| CL2016001546A1 (es) | Composición para el cuidado oral que comprende serina y al menos una sal de zinc. | |
| PH12015501013A1 (en) | Bar soap composition and method of manufacture | |
| MX2016005473A (es) | Metodos y composiciones para mejorar la funcion renal. | |
| MX382374B (es) | Nutrición infantil que proporciona beneficios metabólicos. | |
| EP3466427A4 (en) | SLEEPING AGENT | |
| BR112015032668A2 (pt) | composição e método de preparação de composição | |
| PL406123A1 (pl) | Portal internetowy: Twarzą w Twarz | |
| Al-Daghman | One of the indications of addition in the Quranic context Manifestations of the intention of the appointment and the ratio by adding the pronoun (ha) to the formula (verbs) in the light of appropriate knowledge | |
| TR201900511T4 (tr) | Metalik ditiyokarbamatların preparasyonuna yönelik yöntem. | |
| IN2013CH04898A (https=) | ||
| TR201010571U (tr) | Sunum ve bakım kiti. | |
| CN302559563S (zh) | 电梯专用应急照明电源(d型) | |
| CN302554027S (zh) | 抽屉照明器 | |
| UA88327U (ru) | Способ лечения генерализованного пародонтита при сахарном диабете типа 2 |